Skip to main content

Risk-Benefit Assessment of Drugs Round-Table Discussion (Summary)

  • Conference paper
Prognose- und Entscheidungsfindung in der Medizin

Part of the book series: Medizinische Informatik und Statistik ((MEDINFO,volume 62))

  • 38 Accesses

Abstract

The ideas put forth in the foregoing papers flew into a round-table discussion, in which, as an additional member, Oscar Vanderbeke was called to express the views of the biostatistician.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Jesdinsky, H.J. (1985). Risk-Benefit Assessment of Drugs Round-Table Discussion (Summary). In: Jesdinsky, H.J., Trampisch, H.J. (eds) Prognose- und Entscheidungsfindung in der Medizin. Medizinische Informatik und Statistik, vol 62. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82651-1_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-82651-1_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-16068-7

  • Online ISBN: 978-3-642-82651-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics